Gamboa J, El Attar R, Thuau D, Estrany F, Abbas M, Torras J
Mikrochim Acta. 2024; 191(10):639.
PMID: 39354107
PMC: 11445364.
DOI: 10.1007/s00604-024-06722-5.
Tanaka M, Vecsei L
J Neural Transm (Vienna). 2024; 131(12):1367-1387.
PMID: 39110245
PMC: 11608389.
DOI: 10.1007/s00702-024-02812-z.
Buzenchi Proca T, Solcan C, Solcan G
Life (Basel). 2024; 14(5).
PMID: 38792660
PMC: 11122474.
DOI: 10.3390/life14050640.
Almikhlafi M
Neurosciences (Riyadh). 2024; 29(1):4-9.
PMID: 38195133
PMC: 10827020.
DOI: 10.17712/nsj.2024.1.20230062.
Shamsdin S, Khazraei H, Rahimi Jaberi A, Zamani M, Monjezi M
Middle East J Dig Dis. 2023; 14(1):96-102.
PMID: 36619735
PMC: 9489332.
DOI: 10.34172/mejdd.2022.261.
Exercise Intolerance and Oxygen Desaturation in Patients with Parkinson's Disease: Triggers for Respiratory Rehabilitation?.
Vitacca M, Olivares A, Comini L, Vezzadini G, Langella A, Luisa A
Int J Environ Res Public Health. 2021; 18(23).
PMID: 34886018
PMC: 8656612.
DOI: 10.3390/ijerph182312298.
Mechanistic Insight from Preclinical Models of Parkinson's Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy.
Delgado-Minjares K, Martinez-Fong D, Martinez-Davila I, Banuelos C, Gutierrez-Castillo M, Blanco-Alvarez V
Int J Mol Sci. 2021; 22(21).
PMID: 34769132
PMC: 8583859.
DOI: 10.3390/ijms222111702.
Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.
Antipova V, Holzmann C, Hawlitschka A, Witt M, Wree A
Toxins (Basel). 2021; 13(7).
PMID: 34357977
PMC: 8310221.
DOI: 10.3390/toxins13070505.
Neuropeptide-S affects cognitive impairment and depression-like behavior on MPTP induced experimental mouse model of Parkinson’s disease.
Ozkan A, Bulbul M, Derin N, Sinen O, Akcay G, Parlak H
Turk J Med Sci. 2021; 51(6):3126-3135.
PMID: 34289654
PMC: 10734830.
DOI: 10.3906/sag-2105-74.
Glucocerebrosidase reduces the spread of protein aggregation in a Drosophila melanogaster model of neurodegeneration by regulating proteins trafficked by extracellular vesicles.
Jewett K, Thomas R, Phan C, Lin B, Milstein G, Yu S
PLoS Genet. 2021; 17(2):e1008859.
PMID: 33539341
PMC: 7888665.
DOI: 10.1371/journal.pgen.1008859.
Acupuncture in the treatment of fatigue in Parkinson's disease: A protocol for systematic review and meta-analysis.
Zhi Y, Gao C
Medicine (Baltimore). 2020; 99(48):e23389.
PMID: 33235114
PMC: 7710230.
DOI: 10.1097/MD.0000000000023389.
Ocular fixations and presaccadic potentials to explain pareidolias in Parkinson's disease.
Revankar G, Hattori N, Kajiyama Y, Nakano T, Mihara M, Mori E
Brain Commun. 2020; 2(1):fcaa073.
PMID: 32954309
PMC: 7425388.
DOI: 10.1093/braincomms/fcaa073.
Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in .
Fernandez-Cruz I, Sanchez-Diaz I, Narvaez-Padilla V, Reynaud E
IBRO Rep. 2020; 9:65-77.
PMID: 32715147
PMC: 7369354.
DOI: 10.1016/j.ibror.2020.07.001.
Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides.
Yu J, Min D, Bai Y, Qu L, Zou T, Wang S
Exp Anim. 2020; 69(4):448-460.
PMID: 32669479
PMC: 7677085.
DOI: 10.1538/expanim.19-0153.
Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.
Cutsforth-Gregory J, Low P
Neurol Ther. 2019; 8(2):307-324.
PMID: 31456212
PMC: 6946781.
DOI: 10.1007/s40120-019-00152-9.
Feasibility and Acceptability of Computerised Cognitive Training of Everyday Cognition in Parkinson's Disease.
Smith S, McMillan I, Leroi I, Champ C, Barr S, McDonald K
Parkinsons Dis. 2019; 2019:5258493.
PMID: 31428303
PMC: 6679888.
DOI: 10.1155/2019/5258493.
Olfactory Training Prevents Olfactory Dysfunction Induced by Bulbar Excitotoxic Lesions: Role of Neurogenesis and Dopaminergic Interneurons.
Marin C, Laxe S, Langdon C, Alobid I, Berenguer J, Fuentes M
Mol Neurobiol. 2019; 56(12):8063-8075.
PMID: 31177483
DOI: 10.1007/s12035-019-1639-6.
Organic Electrochemical Transistors/SERS-Active Hybrid Biosensors Featuring Gold Nanoparticles Immobilized on Thiol-Functionalized PEDOT Films.
Chou J, Chung C, Ho P, Luo C, Tsai Y, Wu C
Front Chem. 2019; 7:281.
PMID: 31106195
PMC: 6498878.
DOI: 10.3389/fchem.2019.00281.
HSP90 and Its Novel Co-Chaperones, SGT1 and CHP-1, in Brain of Patients with Parkinson's Disease and Dementia with Lewy Bodies.
Bohush A, Niewiadomska G, Weis S, Filipek A
J Parkinsons Dis. 2019; 9(1):97-107.
PMID: 30741686
PMC: 6398563.
DOI: 10.3233/JPD-181443.
Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.
Vaz R, Outeiro T, Ferreira J
Front Neurol. 2018; 9:347.
PMID: 29910763
PMC: 5992294.
DOI: 10.3389/fneur.2018.00347.